Institutional investors purchased a net $332.1 thousand shares of PDLI during the quarter ended June 2016 and now own 77.40% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RUSSELL INVESTMENT MANAGEMENT LL... Bought 3.0 Million shares of PDL BioPharma Inc
MACKENZIE FINANCIAL CORP. Bought 1.6 Million shares of PDL BioPharma Inc
THE VANGUARD GROUP, INC. Bought 561.4 Thousand shares of PDL BioPharma Inc